Myriad Genetics
MYGN
#6699
Rank
$0.66 B
Marketcap
$7.09
Share price
-3.27%
Change (1 day)
-56.66%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of September 2025 : $0.37 Billion USD

According to Myriad Genetics's latest financial reports the company has $0.37 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.70 B-10.48%
2023-12-31$$0.78 B-11.58%
2022-12-31$$0.88 B-8.47%
2021-12-31$$0.96 B
2020-06-30$$0.91 B-15.68%
2019-06-30$$1.08 B12.71%
2018-06-30$$0.96 B25.79%
2017-06-30$$0.76 B2.66%
2016-06-30$$0.74 B12.99%
2015-06-30$$0.66 B-7.91%
2014-06-30$$0.71 B-1.32%
2013-06-30$$0.72 B14.62%
2012-06-30$$0.63 B12.15%
2011-06-30$$0.56 B1.65%
2010-06-30$$0.55 B28.41%
2009-06-30$$0.43 B2.01%
2008-06-30$$0.42 B25.06%
2007-06-30$$0.34 B36.26%
2006-06-30$$0.24 B84.11%
2005-06-30$$0.13 B-21.7%
2004-06-30$$0.17 B5.99%
2003-06-30$$0.16 B26.86%
2002-06-30$$0.12 B-7.66%
2001-06-30$$0.13 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Bio-Rad Laboratories
BIO
$6.73 B 1,707.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
$2.50 B 570.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
$0.29 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.05 B 1,524.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$51.26 B 13,651.07%๐Ÿ‡บ๐Ÿ‡ธ USA